Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Raynaud's phenomenon
ADR ID BADD_A03708
ADR Hierarchy
24      Vascular disorders
24.04      Arteriosclerosis, stenosis, vascular insufficiency and necrosis
24.04.03      Peripheral vasoconstriction, necrosis and vascular insufficiency
24.04.03.003      Raynaud's phenomenon
Description An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress. [MeSH]
MedDRA Code 10037912
MeSH ID D011928
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Raynaud like disorder | Raynaud's disease | Raynaud's disease aggravated | Raynaud's phenomenon | Raynaud's phenomenon aggravated | Raynaud's syndrome | Raynaud-like disorder | Raynaud-like phenomena | Raynauds | Raynauds phenomena of feet | Raynauds' phen | Raynaud Disease | Cold Fingers, Hereditary | Raynaud's Disease | Raynauds Disease | Raynaud Phenomenon
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01818Pramipexole dihydrochloride--
BADD_D01834Prednisone0.000013%
BADD_D01835Pregabalin0.000104%
BADD_D01846Procarbazine--
BADD_D01867Propranolol0.000198%
BADD_D01909Ramipril0.000606%
BADD_D01951Risperidone0.000182%
BADD_D02047Sodium oxybate0.001395%
BADD_D02058Sorafenib0.000246%
BADD_D02093Sulfasalazine0.000303%
BADD_D02098Sumatriptan--
BADD_D02099Sumatriptan succinate--
BADD_D02160Terbinafine0.000223%
BADD_D02165Teriflunomide0.000892%
BADD_D02192Thalidomide--
BADD_D02214Ticagrelor0.001061%
BADD_D02219Timolol--
BADD_D02220Timolol maleate--
BADD_D02236Tofacitinib0.006004%
BADD_D02247Topiramate0.000050%
BADD_D02268Treprostinil0.000082%
BADD_D02331Valsartan0.000053%
BADD_D02346Venlafaxine0.000032%
BADD_D02359Vinblastine sulfate--
BADD_D02369Voriconazole0.008713%
BADD_D02407Upadacitinib--
BADD_D02440Lisdexamfetamine0.001725%
BADD_D02441Rasagiline0.001624%
BADD_D02452Icatibant-
BADD_D02464Fingolimod0.000362%
The 3th Page    First    Pre   3 4    Next   Last    Total 4 Pages
ADReCS-Target
ADR Term Drug Name Target